ArticleCureus2024

A Prospective, Observational, Open-Label, Non-comparative, Multi-center Study for the Evaluation of Efficacy and Safety of Levonadifloxacin (Intravenous and Oral) in Patients With Community-Acquired Bacterial Pneumonia.

Abhijit Telkhade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.